(Q43720863)

26 November 2017

title

Do statins afford neuroprotection in patients with cerebral ischaemia and stroke? (English)

1 reference

26 November 2017

1 reference

C J Vaughan

1

1 reference

26 November 2017

N Delanty

series ordinal

2

1 reference

26 November 2017

C T Basson

series ordinal

3

1 reference

26 November 2017

publication date

1 January 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

15

1 reference

26 November 2017

issue

8

1 reference

26 November 2017

page(s)

589-596

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200115080-00002

26 November 2017

exact match

0 references

cites work

Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells

1 reference

12 December 2020

Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine

1 reference

12 December 2020

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

1 reference

12 December 2020

Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine

1 reference

12 December 2020

Statins and the risk of dementia

1 reference

12 December 2020

Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration

1 reference

12 December 2020

Role of oxidants in ischemic brain damage

1 reference

12 December 2020

The effect of Simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolaemia

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events

1 reference

12 December 2020

Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation

1 reference

12 December 2020

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

1 reference

12 December 2020

Oxidative injury in the nervous system.

1 reference

12 December 2020

HMG-CoA Reductase Inhibitors Decrease CD11b Expression and CD11b-Dependent Adhesion of Monocytes to Endothelium and Reduce Increased Adhesiveness of Monocytes Isolated From Patients With Hypercholesterolemia

1 reference

12 December 2020

Cytokines and cell adhesion molecules in cerebral ischemia: experimental bases and therapeutic perspectives.

1 reference

12 December 2020

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

1 reference

12 December 2020

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

1 reference

12 December 2020

Pravastatin Therapy and the Risk of Stroke

1 reference

12 December 2020

Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group

1 reference

12 December 2020

Interleukin-1 beta mRNA expression in ischemic rat cortex

1 reference

12 December 2020

Differential regulation by cytokines of human astrocyte nitric oxide production

1 reference

12 December 2020

The cellular functions of small GTP-binding proteins

1 reference

12 December 2020

Neuroprotection mediated by changes in the endothelial actin cytoskeleton.

1 reference

12 December 2020

Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth

1 reference

12 December 2020

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

12 December 2020

Statins as a newly recognized type of immunomodulator

1 reference

12 December 2020

Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene.

1 reference

12 December 2020

The design of a prospective study of pravastatin in the elderly at risk (PROSPER)

1 reference

12 December 2020

Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages

1 reference

12 December 2020

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

1 reference

12 December 2020

Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis.

1 reference

12 December 2020

Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial

1 reference

12 December 2020

Oxidized LDL-induced leukocyte/endothelium interaction in vivo involves the receptor for platelet-activating factor

1 reference

12 December 2020

Statins do more than just lower cholesterol

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

The evolving role of statins in the management of atherosclerosis

1 reference

12 December 2020

Nitric oxide synthase in models of focal ischemia

1 reference

12 December 2020

Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II)

1 reference

12 December 2020

Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice

1 reference

12 December 2020

Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors

1 reference

12 December 2020

Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats.

1 reference

12 December 2020

Vascular effects of statins in stroke

1 reference

12 December 2020

Reductase inhibitor monotherapy and stroke prevention

1 reference

12 December 2020

Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats

1 reference

12 December 2020

Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL

1 reference

12 December 2020

Effect of mevalonate availability on the association of G-protein alpha-subunits with the plasma membrane in GH4C1 cells

1 reference

12 December 2020

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

12 December 2020

10.2165/00023210-200115080-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

26 November 2017

1019575281

0 references

1 reference